Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry.
McKay RR, Gold T, Zarif JC, Chowdhury-Paulino IM, Friedant A, Gerke T, Grant M, Hawthorne K, Heath E, Huang FW, Jackson MD, Mahal B, Ogbeide O, Paich K, Ragin C, Rencsok EM, Simmons S, Yates C, Vinson J, Kantoff PW, George DJ, Mucci LA. McKay RR, et al. Among authors: gerke t. JCO Glob Oncol. 2021 Apr;7:495-505. doi: 10.1200/GO.20.00571. JCO Glob Oncol. 2021. PMID: 33835826 Free PMC article.
Association of prostate cancer risk variants with gene expression in normal and tumor tissue.
Penney KL, Sinnott JA, Tyekucheva S, Gerke T, Shui IM, Kraft P, Sesso HD, Freedman ML, Loda M, Mucci LA, Stampfer MJ. Penney KL, et al. Among authors: gerke t. Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):255-60. doi: 10.1158/1055-9965.EPI-14-0694-T. Epub 2014 Nov 4. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25371445 Free PMC article.
Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM, Mondul AM, Lindström S, Tsilidis KK, Travis RC, Gerke T, Albanes D, Mucci LA, Giovannucci E, Kraft P; Breast and Prostate Cancer Cohort Consortium Group. Shui IM, et al. Among authors: gerke t. Cancer. 2015 Jun 15;121(12):1949-56. doi: 10.1002/cncr.29320. Epub 2015 Mar 2. Cancer. 2015. PMID: 25731953 Free PMC article.
Tumor expression of adiponectin receptor 2 and lethal prostate cancer.
Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA, Giovannucci EL, Loda M, Mucci LA, Finn S; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Rider JR, et al. Among authors: gerke t. Carcinogenesis. 2015 Jun;36(6):639-47. doi: 10.1093/carcin/bgv048. Epub 2015 Apr 11. Carcinogenesis. 2015. PMID: 25863129 Free PMC article.
Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer.
Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson SO, Johansson JE, Fiorentino M, Finn S, Fedele G, Stampfer M, Kantoff PW, Mucci LA, Loda M. Martin NE, et al. Among authors: gerke t. Mol Cancer Res. 2015 Oct;13(10):1431-40. doi: 10.1158/1541-7786.MCR-14-0569. Epub 2015 Jun 29. Mol Cancer Res. 2015. PMID: 26124442 Free PMC article.
Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer.
Lu D, Sinnott JA, Valdimarsdóttir U, Fang F, Gerke T, Tyekucheva S, Fiorentino M, Lambe M, Sesso HD, Sweeney CJ, Wilson KM, Giovannucci EL, Loda M, Mucci LA, Fall K. Lu D, et al. Among authors: gerke t. Clin Cancer Res. 2016 Feb 1;22(3):765-772. doi: 10.1158/1078-0432.CCR-15-0101. Epub 2015 Oct 21. Clin Cancer Res. 2016. PMID: 26490316 Free PMC article.
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL. Ahearn TU, et al. Among authors: gerke t. J Natl Cancer Inst. 2015 Nov 27;108(2):djv346. doi: 10.1093/jnci/djv346. Print 2016 Feb. J Natl Cancer Inst. 2015. PMID: 26615022 Free PMC article.
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.
Preston MA, Batista JL, Wilson KM, Carlsson SV, Gerke T, Sjoberg DD, Dahl DM, Sesso HD, Feldman AS, Gann PH, Kibel AS, Vickers AJ, Mucci LA. Preston MA, et al. Among authors: gerke t. J Clin Oncol. 2016 Aug 10;34(23):2705-11. doi: 10.1200/JCO.2016.66.7527. Epub 2016 Jun 13. J Clin Oncol. 2016. PMID: 27298404 Free PMC article.
Cholesterol Metabolism and Prostate Cancer Lethality.
Stopsack KH, Gerke TA, Sinnott JA, Penney KL, Tyekucheva S, Sesso HD, Andersson SO, Andrén O, Cerhan JR, Giovannucci EL, Mucci LA, Rider JR. Stopsack KH, et al. Cancer Res. 2016 Aug 15;76(16):4785-90. doi: 10.1158/0008-5472.CAN-16-0903. Epub 2016 Jun 20. Cancer Res. 2016. PMID: 27325648 Free PMC article.
110 results